LINC00881 and obesity disorder: Importantly, LIPTER overexpression mitigates cardiomyopathies and preserves cardiac functions in mouse models of obesity and diabetes, highlighting LIPTER’s potential clinical relevance in treating human metabolic syndrome-associated heart disease and failure.